234 related articles for article (PubMed ID: 19853923)
21. Chlamydia trachomatis paralyses neutrophils to evade the host innate immune response.
Rajeeve K; Das S; Prusty BK; Rudel T
Nat Microbiol; 2018 Jul; 3(7):824-835. PubMed ID: 29946164
[TBL] [Abstract][Full Text] [Related]
22. Vaccines for Chlamydia infections of the female genital tract.
Hafner LM; McNeilly C
Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.
Shaw J; Grund V; Durling L; Crane D; Caldwell HD
Infect Immun; 2002 Mar; 70(3):1097-105. PubMed ID: 11854188
[TBL] [Abstract][Full Text] [Related]
24. Chlamydia-secreted protease CPAF degrades host antimicrobial peptides.
Tang L; Chen J; Zhou Z; Yu P; Yang Z; Zhong G
Microbes Infect; 2015 Jun; 17(6):402-8. PubMed ID: 25752416
[TBL] [Abstract][Full Text] [Related]
25. [Chlamydia trachomatis proteasome protein as one of the significant pathogenicity factors of exciter].
Davydov DIu; Zigangirova NA
Mol Gen Mikrobiol Virusol; 2014; (2):3-8. PubMed ID: 25080811
[TBL] [Abstract][Full Text] [Related]
26. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
Poston TB; Gottlieb SL; Darville T
Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
[TBL] [Abstract][Full Text] [Related]
27. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
[TBL] [Abstract][Full Text] [Related]
28. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP
Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
[TBL] [Abstract][Full Text] [Related]
29. The Chlamydia-Secreted Protease CPAF Promotes Chlamydial Survival in the Mouse Lower Genital Tract.
Yang Z; Tang L; Shao L; Zhang Y; Zhang T; Schenken R; Valdivia R; Zhong G
Infect Immun; 2016 Sep; 84(9):2697-702. PubMed ID: 27382018
[TBL] [Abstract][Full Text] [Related]
30. The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.
Murphey C; Murthy AK; Meier PA; Neal Guentzel M; Zhong G; Arulanandam BP
Cell Immunol; 2006 Aug; 242(2):110-7. PubMed ID: 17116296
[TBL] [Abstract][Full Text] [Related]
31. Chlamydia trachomatis Plasmid Gene Protein 3 Is Essential for the Establishment of Persistent Infection and Associated Immunopathology.
Yang C; Kari L; Lei L; Carlson JH; Ma L; Couch CE; Whitmire WM; Bock K; Moore I; Bonner C; McClarty G; Caldwell HD
mBio; 2020 Aug; 11(4):. PubMed ID: 32817110
[No Abstract] [Full Text] [Related]
32. Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity.
Prusty BK; Chowdhury SR; Gulve N; Rudel T
Front Cell Infect Microbiol; 2018; 8():183. PubMed ID: 29900129
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
[TBL] [Abstract][Full Text] [Related]
34. Cleavage of the NF-κB family protein p65/RelA by the chlamydial protease-like activity factor (CPAF) impairs proinflammatory signaling in cells infected with Chlamydiae.
Christian J; Vier J; Paschen SA; Häcker G
J Biol Chem; 2010 Dec; 285(53):41320-7. PubMed ID: 21041296
[TBL] [Abstract][Full Text] [Related]
35. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
[TBL] [Abstract][Full Text] [Related]
36. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
[TBL] [Abstract][Full Text] [Related]
37. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
[TBL] [Abstract][Full Text] [Related]
38. Chlamydia trachomatis outer membrane complex protein B (OmcB) is processed by the protease CPAF.
Hou S; Lei L; Yang Z; Qi M; Liu Q; Zhong G
J Bacteriol; 2013 Mar; 195(5):951-7. PubMed ID: 23222729
[TBL] [Abstract][Full Text] [Related]
39. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Brunham RC; Rey-Ladino J
Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections.
Hafner LM
Contraception; 2015 Aug; 92(2):108-15. PubMed ID: 25592078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
